Use of the hollow fiber assay for the discovery of novel anticancer agents from fungi

Methods in Molecular Biology

Volumn 944, Issue , 2012, Pages 267-277

  Pearce, Cedric J ^a   Lantvit, Daniel D ^a   Shen, Qi ^a   Jarjoura, David ^a   Zhang, Xiaoli ^a   Oberlies, Nicholas H ^a   Kroll, David J ^a   Wani, Mansukh C ^a   Orjala, Jimmy ^a   Soejarto, Djaja D ^a   Farnsworth, Norman R ^a   De Blanco, Esperanza J Carcache ^a   Fuchs, James R ^a   Kinghorn, A Douglas ^a   Swanson, Steven M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Animal models; Cancer; Drug discovery; Fungi; Natural products

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DETERMINATION; FIBER; FUNGUS; HOLLOW FIBER; HOLLOW FIBER ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE DEFICIENCY; IN VIVO STUDY; MACROMOLECULE; MOUSE; NONHUMAN; PARTICLE SIZE; PERITONEAL CAVITY; PRIORITY JOURNAL; TOXICITY; XENOGRAFT;

EID: 84934439853     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-122-6_20     Document Type: Article

References (15)

1. Hassan SB, de la Torre M, Nygren P, Karlsson MO, Larsson R, Jonsson E (2001) A hollowfiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828. Anticancer Drugs 12:33-42
2. Hollingshead M, Roberson J, Decker W, Buckheit R Jr, Elder C, Malspeis L, Mayo J, Grever M (1995) In vivo drug screening applications of HIV-infected cells cultivated within hollowfibers in two physiologic compartments of mice. Antiviral Res 28:265-279
3. Hollingshead MG, Bonomi CA, Borgel SD, Carter JP, Shoemaker R, Melillo G, Sausville EA (2004) A potential role for imaging technology in anticancer efficacy evaluations. Eur J Cancer 40:890-898
4. Mi Q, Pezzuto JM, Farnsworth NR, Wani MC, Kinghorn AD, Swanson SM (2009) Use of the in vivo hollowfiber assay in natural products anticancer drug discovery. J Nat Prod 72:573-580
5. Kinghorn AD, Chin YW, Swanson SM (2009) Discovery of natural product anticancer agents from biodiverse organisms. Curr Opin Drug Discov Devel 12:189-196
6. Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, Grever MR (1995) In vivo cultivation of tumor cells in hollowfibers. Life Sci 57:131-141
7. Davis J (2011) Animal cell culture: essential methods. Wiley, Hoboken
8. Freshney RI (2010) Culture of animal cells: a manual of basic technique and specialized applications, 6th edn. Wiley-Liss, Hoboken
9. Strober W (1997) Trypan blue exclusion test of cell viability. Curr Protoc Immunol, A.3B.1-A.3B.2
10. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
11. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR (1991) Tetrazoliumbased assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 51:2515-2520
12. Decker S, Hollingshead M, Bonomi CA, Carter JP, Sausville EA (2004) The hollowfibre model in cancer drug screening: the NCI experience. Eur J Cancer 40:821-826
13. Developmental Therapeutics Program, US National Cancer Institute. http://dtp.nci.nih. gov/dtpstandard/dwindex/index.jsp . Accessed July 28, 2012.
14. Shnyder SD, Hasan J, Cooper PA, Pilarinou E, Jubb E, Jayson GC, Bibby MC (2005) Development of a modified hollowfibre assay for studying agents targeting the tumour neovasculature. Anticancer Res 25:1889-1894
15. Developmental Therapeutics Program, US National Cancer Institute. http://dtp.nci.nih. gov/branches/btb/acute-tox.html . Accessed July 28, 2012.